Back | Next |
home / stock / zyme / zyme message board
Subject | By | Source | When |
---|---|---|---|
Everyone wants a part of us !! $ZYME to | budgetthis | investorshub | 05/03/2022 7:34:43 PM |
Good Afternoon my Friend! $ZYME is looking Good! | DTGoody | investorshub | 05/02/2022 7:26:37 PM |
I just woke up from a hard West | budgetthis | investorshub | 05/02/2022 3:19:19 PM |
$ZYME is on Fire this Morning, and nobody | DTGoody | investorshub | 05/02/2022 2:52:04 PM |
$ZYME Getting a nice Rip Here! Let's hope | DTGoody | investorshub | 05/02/2022 2:28:31 PM |
Well that's far from $50 lol | Brokemillwright | investorshub | 05/02/2022 2:36:24 AM |
means its not binding | TheFinalCD | investorshub | 04/29/2022 8:40:53 PM |
What non biding offer mean | Pt3 | investorshub | 04/29/2022 7:33:11 PM |
This would go over $10 instantly until the | DTGoody | investorshub | 04/29/2022 5:52:41 PM |
What happen if they accept the offer | Pt3 | investorshub | 04/29/2022 5:49:43 PM |
Same here got some $7.50's | DTGoody | investorshub | 04/29/2022 5:48:36 PM |
Bought call for this | Pt3 | investorshub | 04/29/2022 5:23:23 PM |
God is awesome !! | Laszlo1 | investorshub | 04/29/2022 4:13:16 PM |
My friend I am familiar with that verse | Laszlo1 | investorshub | 04/29/2022 4:12:55 PM |
smart point | TheFinalCD | investorshub | 04/29/2022 4:04:17 PM |
Thank You for the kind words | TheFinalCD | investorshub | 04/29/2022 4:00:23 PM |
Smart money I have been following you over | Laszlo1 | investorshub | 04/29/2022 2:02:30 PM |
Non binding offer! Now watch Zwork do | crudeoil24 | investorshub | 04/29/2022 1:09:57 PM |
1 year later??? lol...I was talking about the | dealerschool2006 | investorshub | 04/29/2022 12:43:50 PM |
https://ih.advfn.com/stock-market/NYSE/zymeworks-$ZYME/stock-news/87950474/zymewo | TheFinalCD | investorshub | 04/29/2022 12:33:43 PM |
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that the Un...
VANCOUVER, British Columbia, July 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that manage...
VANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that the Un...